CClinicalTrials.gg
CompletedNCT05880498SMARTUpdated May 30, 2023

Smartphone Mindfulness Autism Research Study

An interventional study of Mindfulness Intervention in Anxiety and Stress, sponsored by Massachusetts Institute of Technology. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-05-30.

Sponsored by Massachusetts Institute of Technology · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 3 months after the study started (first participant enrolled Jan 2022, registered May 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
89
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Individuals diagnosed with autism are also often diagnosed with anxiety disorders. Therefore, having useful strategies to manage stress and anxiety may be particularly helpful for autistic individuals. Mindfulness-based interventions, delivered in-person as well as those offered remotely online, have been found to lower stress and anxiety. Although in-person mindfulness training has been found to be helpful for autistic individuals, there is little research that has studied remote app-based mindfulness training in autistic adults.

This study examines whether a six-week structured intervention, using a mindfulness app, lowers anxiety and stress in autistic adults. Participants were randomly assigned either to an intervention group, which started the intervention immediately, or a wait-list control group, which participated in the same intervention program six-weeks later. Findings will provide important information about the potential for remote app-based mindfulness training to lower stress and anxiety in adults diagnosed with autism.

Read the detailed description

A significant proportion of individuals diagnosed with autism are also diagnosed with one or more anxiety disorders. Since stress and anxiety in autism have been found to exacerbate common symptoms associated with autism, such as sleep problems and sensory sensitivities, having effective strategies to manage anxiety and stress may be particularly beneficial for autistic individuals. Mindfulness-based therapies have been increasingly recognized as promising interventions to reduce stress and anxiety, and improve mental health in individuals with and without autism. Several studies of individuals without autism have demonstrated that remote digital mindfulness training is equally as effective as traditional in-person mindfulness training in reducing stress and anxiety and enhancing well-being. However, there is little research investigating remote app-based mindfulness training for autistic individuals, which could be especially beneficial with this population due to anxiety and other constraints that make in-person training less feasible.

The primary objective is to assess efficacy of a six-week remote self-guided mindfulness intervention in reducing anxiety and stress in autistic adults. Autistic adults were invited to participate in a remote app-based mindfulness study where participants use their smartphones to complete the six-week structured mindfulness intervention. Participants were block randomized (based on initial trait anxiety scores) to either an intervention group or a wait-list control group. The intervention group immediately received the online mindfulness intervention. The wait-list control group received the same intervention program six-weeks later. All sessions and assessments were delivered online; thus participants were allowed maximal flexibility in participating in this fully remote intervention.

Self-reported levels of stress, anxiety, positive and negative emotions, and trait/dispositional mindfulness were measured at four time-points throughout the study: before the intervention, half-way through (at 3 weeks), after the intervention, and at follow-up (6 weeks after the end of the intervention). The wait-list control group was assessed at two additional time-points: before they began their waiting period and half-way through their waiting period (at 3 weeks). The primary aim of the study is to compare between-group (and secondarily, within-group) outcome measures to determine whether stress and anxiety levels decrease after the mindfulness intervention and whether they decrease above and beyond any decreases experienced by the wait-list control group.

Additionally, the study aims to:

  • Determine whether and how changes in mindfulness are associated with changes in anxiety and stress, over the course of the intervention, including whether there is a negative association of mindfulness with stress and anxiety. In using two different measures of mindfulness the specific components of mindfulness can be examined that appear to be most likely to change and most likely to be (negatively) associated with stress and anxiety.
  • Assess the feasibility of such a remote intervention with this sample of autistic adults by examining:

    • percentages of individuals in each group (intervention and wait-list control) who complete various stages of the intervention (e.g., post-test surveys, follow-up surveys).
    • percentages of individuals in each group (intervention and wait-list control) who complete all of the intervention activities, as well as those who complete at least a certain percentage (e.g. 50% and 75%) of the intervention activities.
  • Examine who seems to benefit most from the intervention (by demographic variables, autistic traits, and other baseline measures obtained).

The aim is to have approximately 30 participants per group participate in the intervention and complete follow-up surveys. Individuals initially completed screening questionnaires to determine study eligibility. Eligible individuals were then given baseline measures, which included the outcome measures as well as autistic characterization measures. Participants were then randomly assigned (through block randomization based on baseline trait anxiety scores) to either the intervention group or the wait-list control group.

After completing their pre-intervention surveys participants were instructed to download the Healthy Minds customized application for this study and were then given a start date for the six-week self-guided intervention. They received automated emails instructing them to complete the outcome measures at the time-points specified above.

The intervention consisted of a customized version of the Healthy Minds app, with six-weeks of alternating didactic 'lessons' (each up to 7 minutes in length) and mindfulness 'practices' (either 10 minutes or 15 minutes in length- as chosen by the participant). There were a total of 29 lessons and practices that were part of the structured curriculum. Other optional practices were included on the app as well. Participants were instructed to listen to (at least) one activity per day for 5 days per week, for 6 weeks. They were told that it was suggested (but not required) that they listen to the activities in order, that they could re-listen to activities as they desired, and that they could listen to the optional practices as they saw fit.

Findings from this intervention will provide important information about the feasibility of remote app-based mindfulness training for autistic adults and the potential of remote app-based mindfulness training to reduce stress and anxiety in this population.

02

Conditions studied

  • Anxiety
  • Stress

Keywords

  • Autism
  • Mindfulness
03

In context

Lead sponsor

Massachusetts Institute of Technology is the lead sponsor of 33 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Daily access to smartphone
  • Professional diagnosis of autism spectrum disorder

Exclusion criteria

Exclusion Criteria:

  • Non-corrected hearing impairment (if it impacts their ability to listen to the app)
  • Far below average nonverbal intellectual ability: 2 standard deviations below the mean on the Test My Brain, matrix reasoning subtest (a validated and normed proxy for nonverbal IQ)
  • Listening comprehension skills that may compromise one's ability to understand the lessons and practices in the app: Below 60% correct on the Listening Comprehension measure (created for this study, based on language used in the Healthy Minds app)
  • Ever taken part in a meditation retreat
  • Engaged in meditation practice at least once per week over the past year
  • Used Healthy Minds app ever
  • Prior training with a meditation teacher (other than an introductory course)
  • Practiced meditation daily for the past 6 months
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
89 participants (actual)

Study arms

  • Experimental
    Mindfulness Intervention

    6 week smartphone-based self-guided mindfulness training using a customized version of the Healthy Minds app. Participants were instructed to listen to at least one activity per day for 5 days per week, for 6 weeks. Activities that were part of the structured curriculum consisted of alternating mindfulness didactic 'lessons' (each up to 7 minutes in length) and mindfulness 'practices' (either 10 minutes or 15 minutes in length- as chosen by the participant).

    Behavioral: Mindfulness Intervention

  • No intervention
    Wait-List Control (WLC)

    No intervention was administered during the 6-week wait list control period.

Interventions

  • BehavioralMindfulness Intervention

    Self-guided mindfulness training using a customized version of the Healthy Minds app

06

What researchers measure

Primary outcomes

  1. State-Trait Anxiety Inventory for Adults

    40-item self-report assessing both state anxiety (20 items) and trait anxiety (20 items) on a 4-point Likert scale. Total trait anxiety scores range from 20 to 80. Total state anxiety scores range from 20 to 80. Higher scores are indicative of a greater level of anxiety.

    Time frame: 6 Weeks

  2. Patient-Reported Outcomes Measurement Information System [PROMIS] Anxiety Short Form

    8-item self-report measure of anxiety, on a 5-point Likert scale. Raw scores range from 8 to 40, with higher scores indicating more anxiety.

    Time frame: 6 weeks

Secondary outcomes

  1. State-Trait Anxiety Inventory for Adults

    40-item self-report assessing both state anxiety (20 items) and trait anxiety (20 items) on a 4-point Likert scale. Total trait anxiety scores range from 20 to 80. Total state anxiety scores range from 20 to 80. Higher scores are indicative of a greater level of anxiety.

    Time frame: 12 Weeks

  2. Patient-Reported Outcomes Measurement Information System [PROMIS] Anxiety Short Form

    8-item self-report measure of anxiety, on a 5-point Likert scale. Raw scores range from 8 to 40, with higher scores indicating more anxiety.

    Time frame: 12 weeks

  3. Perceived Stress Scale

    10-item self-report measure of stress, on a 5-point Likert scale. Scores range from 0 to 40. Higher scores signify more stress.

    Time frame: 6 weeks

  4. Perceived Stress Scale

    10-item self-report measure of stress, on a 5-point Likert scale. Scores range from 0 to 40. Higher scores signify more stress.

    Time frame: 12 weeks

  5. Positive and Negative Affect Schedule, Short Form

    20-item self-report of 10 positive and 10 negative emotions, on a 5-point Likert scale, resulting in both a positive and a negative affect score. Scores for each scale range from 10-50, with higher scores on the Positive Affect Score indicating a greater degree of positive emotions, and higher scores on the Negative Affect Score indicating a greater degree of negative emotions.

    Time frame: 6 weeks

  6. Positive and Negative Affect Schedule, Short Form

    20-item self-report of 10 positive and 10 negative emotions, on a 5-point Likert scale, resulting in both a positive and a negative affect score. Scores for each scale range from 10-50, with higher scores on the Positive Affect Score indicating a greater degree of positive emotions, and higher scores on the Negative Affect Score indicating a greater degree of negative emotions.

    Time frame: 12 weeks

Other outcomes

  1. Mindfulness Attention Awareness Scale

    15-item self-report assessing trait mindfulness, on a 6-point Likert scale. Raw scores range from 15 to 90, with higher scores indicating more mindfulness.

    Time frame: 3 weeks

  2. Mindfulness Attention Awareness Scale

    15-item self-report assessing trait mindfulness, on a 6-point Likert scale. Raw scores range from 15 to 90, with higher scores indicating more mindfulness.

    Time frame: 6 weeks

  3. Mindfulness Attention Awareness Scale

    15-item self-report assessing trait mindfulness, on a 6-point Likert scale. Raw scores range from 15 to 90, with higher scores indicating more mindfulness.

    Time frame: 12 weeks

  4. Five Factor Mindfulness Questionnaire -Short Form

    15-item self-report measure of 5 aspects of trait mindfulness, using a 5-point Likert scale. The total raw score ranges from 15 to 75. The raw scores of each of the 5 subscales range from 3 to 15. Higher scores indicate greater levels of trait mindfulness.

    Time frame: 3 weeks

  5. Five Factor Mindfulness Questionnaire -Short Form

    15-item self-report measure of 5 aspects of trait mindfulness, using a 5-point Likert scale. The total raw score ranges from 15 to 75. The raw scores of each of the 5 subscales range from 3 to 15. Higher scores indicate greater levels of trait mindfulness.

    Time frame: 6 weeks

  6. Five Factor Mindfulness Questionnaire -Short Form

    15-item self-report measure of 5 aspects of trait mindfulness, using a 5-point Likert scale. The total raw score ranges from 15 to 75. The raw scores of each of the 5 subscales range from 3 to 15. Higher scores indicate greater levels of trait mindfulness.

    Time frame: 12 weeks

  7. State-Trait Anxiety Inventory for Adults

    40-item self-report assessing both state anxiety (20 items) and trait anxiety (20 items) on a 4-point Likert scale. Total trait anxiety scores range from 20 to 80. Total state anxiety scores range from 20 to 80. Higher scores are indicative of a greater level of anxiety.

    Time frame: 3 Weeks

  8. Patient-Reported Outcomes Measurement Information System [PROMIS] Anxiety Short Form

    8-item self-report measure of anxiety, on a 5-point Likert scale. Raw scores range from 8 to 40, with higher scores indicating more anxiety.

    Time frame: 3 weeks

  9. Perceived Stress Scale

    10-item self-report measure of stress, on a 5-point Likert scale. Scores range from 0 to 40. Higher scores signify more stress.

    Time frame: 3 weeks

  10. Positive and Negative Affect Schedule, Short Form

    20-item self-report of 10 positive and 10 negative emotions, on a 5-point Likert scale, resulting in both a positive and a negative affect score. Scores for each scale range from 10-50, with higher scores on the Positive Affect Score indicating a greater degree of positive emotions, and higher scores on the Negative Affect Score indicating a greater degree of negative emotions.

    Time frame: 3 weeks

07

Study locations

1 site
  • Massachusetts Institute of Technology
    Cambridge, Massachusetts 02139, United States
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data (IPD) related to results in a publication will be available upon request to approved researchers.

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 30, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05880498
Lead sponsor
Massachusetts Institute of Technology
Responsible party
Sponsor
First posted
May 30, 2023
Start date
Jan 30, 2022
Primary completion
Apr 17, 2023
Completion
Apr 17, 2023
Last update
May 30, 2023

Study contacts

John DE Gabrieli, PhD
principal investigator · Massachusetts Institute of Technology
Liron Rozenkrantz, PhD
study director · Massachusetts Institute of Technology

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion